Benjamin Whitlock is a seasoned scientific professional currently serving as a Scientific Lead at Eli Lilly and Company since 2023. Prior to this role, they held various positions including Senior Scientist and Senior Scientific Lead at the same organization. Benjamin's extensive experience includes working as a Scientist at Fate Therapeutics Inc and Takeda Oncology, as well as a PhD Candidate at Weill Cornell Medicine. They began their career with roles at Brandeis University as an Undergraduate Researcher and at Biogen Idec as an Intern. Benjamin earned their PhD from Weill Medical College of Cornell University and holds a BS/MS from Brandeis University.
This person is not in any teams
This person is not in any offices